Cannabidiol (CBD) Market - 2021-2031

April 2025 | 223 pages | ID: C9BF571A425DEN
DataM Intelligence

Abstracts

The Cannabidiol (CBD) Market was valued at USD 3129.40 million in 2021 and is anticipated to reach by 2031, at a CAGR of 0.206 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Cannabidiol (CBD) Market.

This report delivers a comprehensive overview of the Cannabidiol (CBD) Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cannabidiol (CBD) Market. The Cannabidiol (CBD) Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.

Cannabidiol (CBD) Market Scope:

Key Players

• ENDOCA
• Cannoid LLC
• Isodiol International Inc.
• Elixinol
• Aurora Cannabis Inc.
• Pharmahemp d.o.o
• Medical Marijuana Inc.
• Folium Biosciences
• NuLeaf Naturals LLC
• Aphria Inc.
• Canopy Growth Corp.

Major Highlights

This report delivers a comprehensive overview of the Cannabidiol (CBD) Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cannabidiol (CBD) Market. The Cannabidiol (CBD) Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Type
3.2. Market Snippet by Source
3.3. Market Snippet by Grade
3.4. Market Snippet by Application
3.5. Market Snippet by Distribution Channel
3.6. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing demand for several medical applications such as stress relief, diabetes prevention, alleviation of cancer symptoms mitigation of pain, treatment of anxiety and depression, and acne reduction
    4.1.1.2. Increasing prevalence of the chronic diseases with surge in the geriatric population
    4.1.1.3. XX
  4.1.2. Restraints:
    4.1.2.1. Regulatory issues regarding the use of CBD due to its adverse use
    4.1.2.2. Legalization and need permission for use of CBD
    4.1.2.3. XX
  4.1.3. Opportunity
  4.1.4. Rising FDA approvals with growing permission for the cultivation of CBD for medicinal use by several government
  4.1.5. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY TYPE

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.3. Market Attractiveness Index, By Type Segment
  7.3.1. Isolate*
    7.3.1.1. Introduction
    7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  7.3.2. Full Spectrum
  7.3.3. Broad spectrum
  7.3.4. Others

8. BY SOURCE

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.3. Market Attractiveness Index, By Application Segment
  8.3.1. Marijuana*
    8.3.1.1. Introduction
    8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  8.3.2. Hemp

9. BY GRADE

9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
9.3. Market Attractiveness Index, By Grade Segment
  9.3.1. Therapeutic Grade*
    9.3.1.1. Introduction
    9.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  9.3.2. Clinical Grade
  9.3.3. Food Grade

10. BY APPLICATION

10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3. Market Attractiveness Index, By Application Segment
  10.3.1. Pharmaceutical*
    10.3.1.1. Introduction
    10.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  10.3.2. Food & Beverages
  10.3.3. Personal Care & Cosmetics
  10.3.4. Others

11. BY DISTRIBUTION CHANNEL

11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3. Market Attractiveness Index, By Distribution Channel Segment
  11.3.1. Retail Pharmacies*
    11.3.1.1. Introduction
    11.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  11.3.2. Hospital Pharmacies
  11.3.3. Online Stores
  11.3.4. Others

12. BY REGION

12.1. Introduction
12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
12.3. Market Attractiveness Index, By Region
12.4. North America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
  12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.4.8.1. U.S.
    12.4.8.2. Canada
    12.4.8.3. Mexico
12.5. Europe
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
  12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.5.8.1. Germany
    12.5.8.2. U.K.
    12.5.8.3. France
    12.5.8.4. Italy
    12.5.8.5. Spain
    12.5.8.6. Rest of Europe
12.6. South America
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
  12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.6.8.1. Brazil
    12.6.8.2. Argentina
    12.6.8.3. Rest of South America
12.7. Asia Pacific
  12.7.1. Introduction
  12.7.2. Key Region-Specific Dynamics
  12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
  12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.7.8.1. China
    12.7.8.2. India
    12.7.8.3. Japan
    12.7.8.4. Australia
    12.7.8.5. Rest of Asia Pacific
12.8. Middle East and Africa
  12.8.1. Introduction
  12.8.2. Key Region-Specific Dynamics
  12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
  12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Grade
  12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

14.1. ENDOCA*
  14.1.1. Company Overview
  14.1.2. Type Portfolio and Description
  14.1.3. Key Highlights
  14.1.4. Financial Overview
14.2. Cannoid LLC
14.3. Isodiol International Inc.
14.4. Elixinol
14.5. Aurora Cannabis Inc.
14.6. Pharmahemp d.o.o
14.7. Medical Marijuana Inc.
14.8. Folium Biosciences
14.9. NuLeaf Naturals LLC
14.10. Aphria Inc.
14.11. Canopy Growth Corp. (LIST NOT EXHAUSTIVE)

15. DATAM INTELLIGENCE

15.1. Appendix
15.2. About Us and Services
15.3. Contact Us